@article {38, editor = {,}, title = {Ezetimibe plus moderate-intensity statin versus high-intensity statin}, volume = {61}, number = {3}, pages = {38--38}, year = {2023}, doi = {10.1136/dtb.2023.000008}, publisher = {British Medical Journal Publishing Group}, abstract = {Overview of: Kim BK, Hong SJ, Lee YJ, et al. Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial. Lancet. 2022;400:380{\textendash}390}, issn = {0012-6543}, URL = {https://dtb.bmj.com/content/61/3/38}, eprint = {https://dtb.bmj.com/content/61/3/38.full.pdf}, journal = {Drug and Therapeutics Bulletin} }